#16th Pharmacovigilance 2018

16th Pharmacovigilance 2018

16th Pharmacovigilance 2018

16th Pharmacovigilance 2018 is being conducted by Virtue Insight from 02OCT2018 to 04OCT2018. Global Pharmacovigilance Market expected to Reach US$6.1 bn by 2t020 expanding at a CAGR of 14.2% from 2015 to 2020 and also expected to reach a market size of $8.23 billion by 2022. By 2020, the size of the global pharmaceutical market is anticipated to grow to USD 1.3 trillion, with the E7 countries — Brazil, China,
India, Indonesia, Mexico, Russia, and Turkey.

16th Pharmacovigilance 2018 will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues
of the industry. The entire program will cover the detection, analysis and prevention of adverse drug reactions. It will be studied with the help of case studies and industry experiences. This conference will help the drug safety representatives from the pharmaceutical industry and academic and quality research organizations who wish to understand how to avoid common deficiencies in inspections by learning from the experiences of others; to gain a greater understanding of new and existing pv requirements, and to improve their organizations’ compliance with pv requirements. Also, it can help you control your product’s lifecycle, your patient’s trust, and your revenue. Hence, this conference will provide an important platform for pharmacovigilance stakeholders to discuss and share best practices in expediting Pv development. What does the future hold for pv? Find out at our conference on opportunities and activities shaping pv to 2020 with respect to regulations, technologies, and services. Learn and know on what are drug producers and service providers doing? What regulations and technologies influence the current PV field? You can also discover at 16th Pharmacovigilance 2018 on spending forecasts for PV (US, the EU, and Asia).

#16th Pharmacovigilance 2018
16th Pharmacovigilance 2018

Also Read: PV BOOKS


  • Pharmacovigilance in the US: What comes next for the industry?
  • Recent developments – legislation, policies, systems, technology, communication strategies and best practice in PV
  • Optimising the overall PV ecosystem – Challenges and Opportunities
  • Why does pharmacovigilance sometimes fail and where
could the fault lie?
  • Pharmacovigilance and healthcare system
  • Technology Impact – Cloud – Big data – Analytics – AI – Machine learning
  • Updates to PSUR, PBRERs, DSUR, PASS
  • Good Clinical Practices and Good Pharmacovigilance practices
  • Future of outsourced phase I, II and III trials and post-marketing studies
  • Data quality management and analysis – analyzing the new guidelines
  • Strategies to improve clinical trials and PV
  • Maintaining proper balance in relationships: Sponsor – Site – CRO & Patients
  • Patient centric approach to help improve patient safety
  • Outsourcing activities – Choosing your right vendor and setting the path right
  • PV Audit & inspections – preparation, implementation and lessons to be learnt
  • Discover approaches for collecting, integrating and analyzing all of the safety data generated from preclinical models
  • Current regulations and guidelines – USA, EU and RoW
  • The developing regulatory framework in advanced and developing markets
  • Be part of a major networking opportunity

For complete details: Click Here


CEO’s, CTO’s, CIO’s, Presidents, VPs, Directors, Heads, Managers, Scientific Advisors, Consultants of:

  • Pharmacovigilance
  • Pharmacoepidemiology
  • Pharmacogenomics
  • Drug/Product Safety
  • Drug Development
  • Information and Clinical Data Management
  • Clinical Pharmacology
  • Clinical Safety
  • Periodical safety update Reports
  • Risk Management
  • Research & Development
  • Quality Assurance
  • Patient Safety
  • Signal Detection
  • Safety Surveillance
  • Outcomes Research
  • Data Analysis
  • Epidemiology
  • Medical Affairs
  • Regulatory Affairs and Compliance
  • Information technology
  • Sales and Marketing


16th Pharmacovigilance 2018 – “Ensuring safer drugs to market by analyzing the latest developments in pharmacovigilance, drug safety, and risk management”

Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.


                                   Book Online: Click Here

Do not miss to share 16th Pharmacovigilance 2018 on your social connections including, facebook, linkedin and twitter.

Leave a Reply

Your email address will not be published. Required fields are marked *